Zhulin Wu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Long Noncoding Rna

Network Analysis

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Computational and mathematical methods in medicine

International journal of general medicine

Guangzhou University of Chinese Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Guangzhou University of Chinese Medicine Sep 02 2019 - Jun 30 2022

China

PHD :: The Fourth Clinical Medical College

Publications

Taoli Wang, Zhulin Wu, Shiguang Li, Zhong Chen, Yiqi Chen, Zhenjiang Yang
Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma. International journal of general medicine 15 (2022)
Si-Yi Li, Zhulin Wu, Qiuyue Li, Qiting Liang, Hengli Zhou, Yafei Shi, Rong Zhang, Hua-Feng Pan
The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Zhulin Wu, Jianyuan Kang, Wanjun Tan, Chunshan Wei, Li He, Xiaoyan Jiang, Li-Sheng Peng
In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma. Computational and mathematical methods in medicine 2022 (2022)
Zhulin Wu, Chunshan Wei, Lianan Wang, Li He
Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Zhulin Wu, Lina Yang, Li He, Lianan Wang, Li-Sheng Peng
Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)